Sartorius Stedim Biotech S.A
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transp… Read more
Market Cap & Net Worth: Sartorius Stedim Biotech S.A (SDMHF)
Sartorius Stedim Biotech S.A (PINK:SDMHF) has a market capitalization of $19.85 Billion ($19.85 Billion) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #2553 globally and #1789 in its home market, demonstrating a -2.37% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sartorius Stedim Biotech S.A's stock price $204.04 by its total outstanding shares 97290030 (97.29 Million).
Sartorius Stedim Biotech S.A Market Cap History: 2015 to 2025
Sartorius Stedim Biotech S.A's market capitalization history from 2015 to 2025. Data shows growth from $5.97 Billion to $19.85 Billion (15.81% CAGR).
Sartorius Stedim Biotech S.A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sartorius Stedim Biotech S.A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
6.69x
Sartorius Stedim Biotech S.A's market cap is 6.69 times its annual revenue
169.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
74.77x
Sartorius Stedim Biotech S.A's market cap is 74.77 times its annual earnings
862.31x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $5.86 Billion | $1.05 Billion | $153.68 Million | 5.57x | 38.14x |
| 2017 | $6.70 Billion | $1.08 Billion | $161.09 Million | 6.20x | 41.61x |
| 2018 | $9.31 Billion | $1.21 Billion | $208.05 Million | 7.68x | 44.77x |
| 2019 | $15.36 Billion | $1.44 Billion | $234.50 Million | 10.66x | 65.49x |
| 2020 | $34.92 Billion | $1.91 Billion | $335.93 Million | 18.28x | 103.95x |
| 2021 | $53.48 Billion | $2.89 Billion | $414.40 Million | 18.52x | 129.04x |
| 2022 | $31.76 Billion | $3.49 Billion | $876.10 Million | 9.09x | 36.25x |
| 2023 | $25.59 Billion | $2.78 Billion | $309.70 Million | 9.22x | 82.63x |
| 2024 | $17.13 Billion | $2.78 Billion | $175.10 Million | 6.16x | 97.85x |
| 2025 | $19.85 Billion | $2.97 Billion | $265.50 Million | 6.69x | 74.77x |
Competitor Companies of SDMHF by Market Capitalization
Companies near Sartorius Stedim Biotech S.A in the global market cap rankings as of March 18, 2026.
Key companies related to Sartorius Stedim Biotech S.A by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $170.40 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #362 globally with a market cap of $61.18 Billion USD ( €59.61 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.90 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.40 Billion | $482.76 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #362 | EssilorLuxottica S. A. | PA:EL | $61.18 Billion | €203.00 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.90 Billion | $161.64 |
Sartorius Stedim Biotech S.A Historical Marketcap From 2015 to 2025
Between 2015 and today, Sartorius Stedim Biotech S.A's market cap moved from $5.97 Billion to $ 19.85 Billion, with a yearly change of 15.81%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $19.85 Billion | +15.87% |
| 2024 | $17.13 Billion | -33.05% |
| 2023 | $25.59 Billion | -19.42% |
| 2022 | $31.76 Billion | -40.61% |
| 2021 | $53.48 Billion | +53.13% |
| 2020 | $34.92 Billion | +127.39% |
| 2019 | $15.36 Billion | +64.87% |
| 2018 | $9.31 Billion | +38.95% |
| 2017 | $6.70 Billion | +14.35% |
| 2016 | $5.86 Billion | -1.81% |
| 2015 | $5.97 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Sartorius Stedim Biotech S.A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $19.85 Billion USD |
| MoneyControl | $19.85 Billion USD |
| MarketWatch | $19.85 Billion USD |
| marketcap.company | $19.85 Billion USD |
| Reuters | $19.85 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.